Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy

Clinical trial NCT05626634 · COMPLETED

Trial details

NCT number: NCT05626634
Sponsor: Longboard Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Developmental and Epileptic Encephalopathy Dravet Syndrome Lennox-Gastaut Syndrome

Start date: 2022-11-08
Primary completion: 2024-12-20
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.